Citadel Advisors
HOOK

Citadel Advisors’s HOOKIPA Pharma HOOK Stock Holding History

Citadel Advisors’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,366
Closed -$11.2K – 13589
2025
Q1 		$11.2K Sell
10,366
-22,341
-68% -$36.8K ﹤0.01% 13499
2024
Q4 		$65.7K Buy
32,707
+21,534
+193% +$66.6K ﹤0.01% 12061
2024
Q3 		$48K Buy
+11,173
New +$59K ﹤0.01% 11958
2023
Q4 		– Sell
-474
Closed -$2.92K – 14700
2023
Q3 		$2.92K Buy
+474
New +$3.48K ﹤0.01% 13656
2023
Q2 		– Sell
-615
Closed -$6.83K – 14724
2023
Q1 		$4.53K Sell
615
-104
-14% -$932 ﹤0.01% 13948
2022
Q4 		$5.83K Buy
+719
New +$7.79K ﹤0.01% 13963
2022
Q3 		– Sell
-9,681
Closed -$149K – 13030
2022
Q2 		$157K Buy
9,681
+5,528
+133% +$91.5K ﹤0.01% 10943
2022
Q1 		$95K Buy
4,153
+125
+3% +$2.24K ﹤0.01% 12335
2021
Q4 		$94K Sell
4,028
-2,077
-34% -$83.5K ﹤0.01% 12777
2021
Q3 		$360K Sell
6,105
-308
-5% -$22.3K ﹤0.01% 10654
2021
Q2 		$587K Buy
6,413
+4,672
+268% +$623K ﹤0.01% 9681
2021
Q1 		$234K Buy
+1,741
New +$210K ﹤0.01% 11394

Other funds holding HOOK

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors's HOOK Position: Q2 2025 in Review

Citadel Advisors sold out of HOOKIPA Pharma (HOOK) in Q2 2025, closing a stake of 10,366 shares — an estimated $11.2K sold.

Citadel Advisors first reported a position in HOOK in Q1 2021 and held it in 12 quarters. The position peaked at $587K in Q2 2021. 27 funds tracked by Wall St. Rank hold HOOK as of Q2 2025.

  • Citadel Advisors reported no remaining HOOKIPA Pharma position as of Q2 2025 after selling out during the quarter.
  • Citadel Advisors sold 10,366 HOOKIPA Pharma shares in Q2 2025, an estimated $11.2K.
  • Citadel Advisors first reported a position in HOOKIPA Pharma in Q1 2021 and held it in 12 quarters.
  • Citadel Advisors's HOOKIPA Pharma position peaked at $587K in Q2 2021.
  • 27 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.